A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
暂无分享,去创建一个
R. Miller | J. Graeber | R. Auten | A. Rosenberg | M. Hudak | M. Horgan | P. Donohue | D. Durand | V. Carrion | A. Brody | B. Torres | E. Egan | M. M. Riddlesberger | D. Martin | M. Belcastro | M. Balsan | R. Jansen | A. L. Jung | S. Buckwald | E. Farrell | P. Montgomery | E. Matteson | W. Maniscalco | K. Laskay | D. Durand | Michael J. Horgan | Mark L. Hudak | David J. Martin | E. A. Egan | Elizabeth J. Matteson | August L. Jung | Adam A. Rosenberg | Marc R. Belcastro | Pamela K. Donohue | Robert D. Jansen | Alan S. Brody | Merchline M. Riddlesberger | Paul Montgomery | Elaine E. Farrell | Sharon Buckwald | Vivien Carrion | William W. Maniscalco | Benjamin A. Torres | Randy R. Miller | Janet E. Graeber | Kathleen M. Laskay
[1] A. Jobe,et al. Surfactant Protein-B Supplementation Improves In Vivo Function of a Modified Natural Surfactant , 1995, Pediatric Research.
[2] A. Pramanik,et al. Comparison of the effect of three doses of a synthetic surfactant on the alveolar-arterial oxygen gradient in infants weighing > or = 1250 grams with respiratory distress syndrome. American Exosurf Neonatal Study Group II. , 1994, The Journal of pediatrics.
[3] S. Schürch. Surface tension properties of surfactant. , 1993, Clinics in perinatology.
[4] L. Wright,et al. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network. , 1993, The Journal of pediatrics.
[5] P. Langenberg,et al. Pulmonary hemorrhage and exogenous surfactant therapy: a metaanalysis. , 1993, The Journal of pediatrics.
[6] J. Clemens,et al. Prognostic implications of age at detection of air leak in very low birth weight infants requiring ventilatory support. , 1993, The Journal of pediatrics.
[7] H. Segerer,et al. Pulmonary Distribution and Efficacy of Exogenous Surfactant in Lung-Lavaged Rabbits Are Influenced by the Instillation Technique , 1993, Pediatric Research.
[8] R. Soll,et al. Overview of Exogenous Surfactant Replacement Therapy , 1993 .
[9] W. Seeger,et al. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. , 1993, The European respiratory journal.
[10] J. Kattwinkel,et al. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation. , 1993, Pediatrics.
[11] A. Jobe,et al. Pulmonary surfactant therapy. , 1993, The New England journal of medicine.
[12] J. Cummings,et al. A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs. , 1992, The American review of respiratory disease.
[13] R. Cotton,et al. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. , 1991 .
[14] J. Gilhooly,et al. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome. , 1991, Pediatrics.
[15] F. Volberg,et al. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I. , 1991, The Journal of pediatrics.
[16] A. Laptook,et al. Neonatal intracranial hemorrhage: II. Risk factor analysis in an inborn population. , 1990, Early human development.
[17] A. Jobe,et al. Surfactant for the treatment of respiratory distress syndrome. , 1987, The American review of respiratory disease.
[18] R. Bhat,et al. DOUBLE-BLIND CONTROLLED TRIAL OF SINGLE-DOSE TREATMENT WITH BOVINE SURFACTANT IN SEVERE HYALINE MEMBRANE DISEASE , 1987, The Lancet.
[19] C. Meinert. Clinical Trials: Design, Conduct, and Analysis , 1986 .
[20] Barr,et al. Classification of Human-Tumors by High-Resolution Magnetic-Resonance Spectroscopy , 1986 .
[21] R. Notter,et al. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. , 1985, Pediatrics.
[22] G. Enhorning,et al. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. , 1985, Pediatrics.
[23] H. Marsh,et al. Calculation of mean airway pressure during mecanical ventilation in neonates , 1984, Critical care medicine.
[24] P. Farrell,et al. Clinical and roentgenographic scoring systems for assessing bronchopulmonary dysplasia. , 1984, American journal of diseases of children.
[25] J. Volpe,et al. Relationship of pneumothorax to occurrence of intraventricular hemorrhage in the premature newborn. , 1982, Pediatrics.
[26] R. Leblanc,et al. Neonatal intracranial hemorrhage. A clinical and serial computerized tomographic study. , 1980, Journal of neurosurgery.
[27] L. Papile,et al. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. , 1978, The Journal of pediatrics.
[28] A. Jobe,et al. Distribution of surfactant and ventilation in surfactant-treated preterm lambs. , 1994, Journal of applied physiology.
[29] J. Whitsett,et al. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. , 1992, The American review of respiratory disease.